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Background: Chronic pain is a major public health problem. The impact of stages of chronic pain adjusted for
disease load on societal burden has not been assessed in population surveys.
Methods: A cross-sectional survey with 4360 people aged ≥ 14 years representative of the German population was
conducted. Measures obtained included demographic variables, presence of chronic pain (based on the definition
of the International Association for the Study of Pain), chronic pain stages (by chronic pain grade questionnaire),
disease load (by self-reported comorbidity questionnaire) and societal burden (by self-reported number of doctor visits,
nights spent in hospital and days of sick leave/disability in the previous 12 months, and by current unemployment).
Associations between chronic pain stages with societal burden, adjusted for demographic variables and disease load,
were tested by Poisson and logistic regression analyses.
Results: 2508 responses were received. 19.4% (95% CI 16.8% to 22.0%) of participants met the criteria of chronic
non-disabling non-malignant pain. 7.4% (95% CI 5.0% to 9.9%) met criteria for chronic disabling non-malignant pain.
Compared with no chronic pain, the rate ratio (RR) of days with sick leave/disability was 1.6 for non-disabling pain and
6.4 for disabling pain. After adjusting for age and disease load, the RRs increased to 1.8 and 6.8. The RR of doctor visits
was 2.5 for non-disabling pain and 4.5 for disabling pain if compared with no chronic pain. After adjusting for age and
disease load, the RR fell to 1.7 and 2.6. The RR of days in hospital was 2.7 for non-disabling pain and 11.7 for disabling
pain if compared with no chronic pain. After adjusting for age and disease load, the RR fell to 1.5 and 4.0. Unemployment
was predicted by lower educational level (Odds Ratio OR 3.27 [95% CI 1.70-6.29]), disabling pain (OR 3.30 [95% CI
1.76-6.21]) and disease load (OR 1.70 [95% CI 1.41-2.05]).
Conclusion: Chronic pain stages, but also disease load and societal inequalities contributed to societal burden. Pain
measurements in epidemiology research of chronic pain should include chronic pain grades and disease load.
Keywords: Chronic pain, Disease load, Social inequality, General population, Cross-sectional surveyBackground
Neck pain, low back pain and migraine belong to the
nine leading specific causes of years lived with disability
in 1990 and 2010 [1]. The high prevalence of chronic
pain and its negative societal burden provide justification
for regarding chronic pain as a public health priority
[2,3]. However, prevalence estimates of chronic pain in
population studies range from 11% to 64% in [3,4]* Correspondence: andreas.hinz@medizin.uni-leipzig.de
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unless otherwise stated.leaving uncertainty about the real extent of the “pain
problem” [5]. The wide range of prevalence rates of
chronic pain was explained by the use of different defini-
tions of chronic pain (e.g. three versus six months dur-
ation) and wording of the questions on chronic pain in
the studies [6].
In addition, problems with the classification of chronic
pain exclusively based on duration have been discussed.
Studies with primary care patients suggested that a distinc-
tion between acute and chronic pain based on 3-month or
6-month duration may be arbitrary [7,8]. AdditionalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ered when classifying chronic pain [8]. Instruments to dif-
ferentiate between non-disabling and disabling pain have
been developed [9], but were not used by most surveys on
chronic pain in the general population [2,4].
Akin to many other chronic non-communicable dis-
eases across the globe, chronic pain is typically accompan-
ied by somatic and mental comorbidities [3]. Therefore
the burden of chronic pain in terms of health care use or
unemployment could be confounded with the one of asso-
ciated diseases. Thus, there is a need for further research
in this area [10].
In 2003, a computer assisted telephone survey on the
prevalence and impact of chronic pain was conducted in
15 European countries including Germany. However, the
refusal rate was 62% in Germany. 302 Germans with
chronic pain participated in the survey whose demo-
graphic data were not reported. Therefore the validity of
the results of this survey for Germany is questionable
[11]. The German Health Surveys conducted in 1998
and 2012 by the Robert Koch Institute did not assess
chronic pain in adults [12,13]. The 2012 German survey
of our study group did not use validated instruments to
assess chronic pain [14]. In addition, the prevalence of
chronic pain stages has not been studied in Germany
until now. Due to these research gaps, the aims of our
study were to assess
a. The prevalence of chronic pain stages
b. The impact of chronic pain stages on key indicators
of societal burden (days of sick leave/disability,
health care use, unemployment) with and without
adjustment for demographic variables and disease




The study was part of the annual general population sur-
veys conducted by the University of Leipzig in which
political and religious attitudes as well as health topics
were assessed. The participants were informed that the
study has no specific focus.
Study participants, selection criteria, selection methods
and selection procedures
A representative sample of the German population was
selected with the assistance of a demographic consulting
company (USUMA, Berlin, Germany). The random se-
lection was based on multistage sampling. First, 258
sample point regions were randomly drawn from the last
political election register, covering rural and urban areas
from all regions in Germany. The second stage was a
random selection of households using the random routeprocedure (based on a starting address). The third stage
was a random selection of household respondents with
the Kish selection grid. The sample was aimed to be rep-
resentative in terms of age, gender, and education of the
German population. The inclusion criteria for the study
were age at or above 14 and the ability to read and
understand the German language.
All subjects were visited by a study assistant and in-
formed about the investigation. Subjects were presented
with self-rating questionnaires. The survey included sev-
eral questionnaires on somatic and psychological symp-
toms (health survey) as well as questionnaires on eating
behavior, political attitudes and religious topics. The as-
sistant waited until the participants answered all question-
naires, and offered help if persons did not understand the
meaning of questions.
Data collection took place between May and June
2013. A first attempt was made at 4,360 addresses, and
2508 (57.5%) persons participated fully. Reasons for
non-participation included the following: three unsuc-
cessful attempts to contact the household or selected
household member (14.8%); the household or selected
household member declined to participate (13.6%); or
the household member was on a holiday break (0.9%).
Furthermore, 0.4% of the participants were excluded be-
cause they were not able to follow the interview because
of illness, as were 12.4% who refused to finish the inter-
view. 0.4% of interviews could not be analysed because
of missing data.
Questionnaires
Chronic pain and persistent bodily pain
Individuals with chronic nonmalignant pain were identi-
fied by screening questions based on the International
Association of Pain definition of chronic pain (“pain that
persists beyond normal tissue healing time, which is as-
sumed to be 3 months”) [15], as follows: 1. “Did you ex-
perience pain that occurred constantly or flared up
frequently in the last three months?” [16]. 2. Participants
who answered “yes” were asked if the pain was attribut-
able to a malignant disease. If the answer was yes, the
participants were excluded from questions on pain grad-
ing. 3. The bodily pain item (“How much bodily pain
have you had during the last 4 weeks? (no, very mild,
mild, moderate, severe, very severe”)) of the Short Form
Health Survey German version (SF-8) [17] was presented
to every participant with a positive response to question
1. Chronic non-malignant pain was defined by a positive
response in question 1, a negative response in question 2
and the report of at least very mild pain in question 3.
Chronic pain stages
Chronic pain stages were assessed using the Chronic
Pain Grade questionnaire (CPG). The questionnaire
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three months. This seven-item scale then classifies pain
into four hierarchical grades based on severity and dis-
ability: Grade I, low disability—low pain intensity; Grade
II, low disability—high pain intensity; Grade III, high dis-
ability—moderately limiting; and Grade IV, high disabil-
ity—severely limiting [9]. This questionnaire has been
validated for use as a self-completion measure in postal
surveys in the general population [18]. We used the vali-
dated German version of the CPG [19]. For the purpose
of some analyses, individuals were classified into those
with non-disabling chronic pain (CPG 1 and 2) and
those with disabling chronic pain (CPG 3 and 4) [9].
Demographic questionnaire and body mass index
Age, gender, family status, educational level, net family
income per months, current body weight and height
were assessed by a standardized questionnaire used in
previous German health surveys [14].
Disease load
The generic self-administered comorbidity questionnaire
(SCQ) is a frequently used and validated instrument in
clinical and health services research to assess common
diseases which might impact functioning. The SCQ asks
about the presence, treatment and functional limitations
of 12 common diseases and three additional non-specified
medical problems. Three subscale scores (present disease,
present disease with drug treatment, present disease
with associated disability and drug treatment) (0–15
each) and a total score (0–45) can be calculated [20].
We used the German version SCQ-D [21]. Osteoarth-
ritis was substituted by alcohol – or drug abuse in a
German version of SCQ (Sangha and Offenbächer, per-
sonal communication). We excluded “back problems”
from all regression analyses because we aimed to assess
the relative impact of non-painful comorbidities com-
pared to chronic pain stages on societal burden.
Health care utilization
Subjects were asked to rate if and how frequently they
visited doctors (general practitioners, pain management
specialists and other medical specialists) during the pre-
vious 12 months for any reason. The total number of doc-
tor visits in the prior 12 months was calculated. Moreover,
hospitalisation (number of nights staying in hospital) was
assessed. All items on health care utilization were assessed
according to the German National Health Interview and
Examination Survey [22].
Statistical analysis
Because < 5% of items were missing we did not use im-
putation methods [23]. Up to one missing item in the
disability score of the CPG was substituted by theindividual rounded mean. If more items were missing,
the questionnaire was excluded from analysis. Missing
values in the SCQ and Health care utilization question-
naire were coded as zero.
Statistical analyses were conducted with the SPSS 19.0
statistical package and STATA 13.1. Absolute values and
percentages were used for descriptive statistics of cat-
egorical data and means with standard deviations for de-
scriptive statistics of continuous data. Despite multiple
comparisons, alpha-level was set to 0.05 because of the
exploratory and hypothesis-generating design of the
study.
The associations between pain grades and days of sick
leave age/inability to work, number of nights spent in
hospital, number of family physician and specialist visits
within the previous 12 months with and without control
for age and disease load were assessed by Poisson regres-
sion analyses. Results are expressed as rate ratios (RR)
with 95% confidence intervals (CIs). The associations
between demographic factors, chronic pain grades and
comorbidity index with unemployment were examined
using binary logistic regression. Results are expressed as
odds ratios (OR) with 95% confidence intervals (CIs).
Ethics
All participants were informed about the study proce-
dures and signed an informed consent form. For chil-
dren under the age of 18 years the parents or guardians
also gave written informed consent. The study was
approved by the institutional ethics review board of the
University of Leipzig (Az 092-12-05032012).
Results
Sample characteristics
The study sample was approximately representative of the
general German population in terms of age groups, sex
ratio and educational level [24] (see Additional file 1).
Demographic details of the study sample are outlined
in Table 1.
Missing values
The number of missing values of the CPG is presented
in Table 2.
0.3% of the items of the SCQ and 0.2% of the items
of the health care utilization questionnaire were not
answered by the participants.
Prevalence of chronic pain and of chronic pain stages
28.4% of the respondents reported constant or fre-
quently recurring pain in the last 3 months. 5.3% of
these persons reported malignant pain. These persons
were excluded from further analyses. 26.9% reported
pain of any severity in the SF-8 not associated with ma-
lignancies during the last 4 weeks and thus met the
Table 1 Demographic and clinical characteristics of the





Mean (SD) 49.7 (17.3)
Family status
Married/living together 1315 (52.4)
Education
No school finished 67 (2.7)
In school 78 (3.1)
Primary or secondary school 1898 (75.7)
High school or higher 455 (18.1)
Missing 10 (0.4)
Current professional status
Working fulltime 996 (39.7)
Working partial time 310 (12.4)
Without job 142 (5.7)
Pensioner 745 (29.7)
Homemaker 42 (1.7)
Schooling or university education 150 (6.0)
Other (e.g. maternity leave) 19 (0.8)
Missing 104 (4.1)
Family net income per month (€)
< 750 114 ( 4.5)
750 -1250 403 (16.1)
1251-2500 735 (29.3)
> 2500 1180 (47.0)
Missing 76 (3.0)
Table 2 Prevalence rates of chronic pain







710 28.3 (26.6- 30.2) 6 2502
Non-malignant pain 673 26.9 (25.2-28.6)
Malignant pain 37 1.4 (1.35-1.45)
SF-8 bodily pain intensity last
4 weeks (malignant pain
excluded)
7 2464
None 1802 73.1 (71.3-74.9)
Very slight 27 1.0 (0.9-1.1)
Slight 106 4.2 (3.4-5.0)
Moderate 371 15.0 (13.6-16.4)
Strong 141 5.7 (4.6-6.6)
Very strong 17 0.1 (0.08-0.12)
SF-8 bodily pain very slight to
very severe intensity last
4 weeks (malignant pain
excluded) duration
6 663
3-6 months 88 13.2 (10.2-15.8)
7-12 months 64 9.7 (7.5-11.9)
1-3 years 181 27.3 (23.9-30.7)
3-5 years 145 21.9 (18.8-25.0)
5-10 years 101 15.2 (12.5-17.9)
> 10 years 84 12.7 (10.2-14.2)
Chronic pain stages
(referred to total sample)
2 2452
I 271 11.1 (9.8-12.2)
II 207 8.4 (7.3-9.5)
III 122 5.0 (4.1-5.8)
IV 60 2.4 (1.9-2.9)
Chronic pain stages (referred
to persons with chronic
non-malignant pain)
2 660
I 271 41.1 (37.4-44.8)
II 207 31.4 (27.9-34.9)
III 122 18.5 (15.5-21.5)
IV 60 9.0 (7.9-11.2)
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21.5% met the SF-8 criterion of persistent bodily pain
(at least moderate pain intensity in last 4 weeks). 19.5%
of respondents met the criteria of chronic- non disabling
pain and 7.4% met the criteria of chronic disabling pain
(see Tables 2 and 3).Societal burden of chronic pain stages
Compared with no chronic pain, the rate ratio of days
with sick leave/disability was increased 1.6 times for
non-disabling pain and 6.4 times for disabling pain.
After adjusting for age and disease load, the RRs was in-
creased to 1.8 and 6.8 (see Table 3).
Compared with no chronic pain, the rate ratio of doctor
visits was increased 2.5 times for non-disabling pain and
4.5 times for disabling pain. After adjusting for age and
disease load, the RRs fell to 1.7 and 2.6 (see Table 3).Compared with no chronic pain, the rate ratio of days
in hospital was increased 2.7 times for non-disabling
pain and 11.7 times for disabling pain. After adjusting
for age and disease load, the RRs fell to 1.5 and 4.0 (see
Table 3).
Lower education level (OR 3.27, 95% CI 1.70 to 6.29),
disabling chronic pain (OR 3.30, 95% CI 1.76 to 6.21)
and disease load with drug treatment (OR 1.70, 95% CI
1.41 to 2.05) predicted unemployment compared with
persons working full or half time (see Table 4).
Table 3 Societal burden of chronic pain stages without and with adjustment for age and disease load (N = 2452)
Pain stages Variable Mean (Minimum- maximum) Unadjusted rate ratio (95% CI) Adjusted rate ratio (95% CI)
No pain Days of sick leave/disability 3.9 (0–365) 1.0 1.0
Non-disabling pain 6.4 (0–336) 1.6 (1.5-1.7) 1.8 (1.7-1.9)
Disabling pain 24.8 (0–365) 6.4 (6.1-6.6) 6.8 (6.5-7.1)
No pain Doctor visits 3.4 (0–50) 1.0 1.0
Non-disabling pain 8.4 (0–60) 2.5 (2.4-2.8) 1.7 (1.6-1.8)
Disabling pain 15.1 (0–70) 4.5 (4.3-4.7) 2.6 (2.4-2.7)
No pain Nights in hospital 0.6 (0–80) 1.0 1.0
Non-disabling pain 1.7 (0–72) 2.7 (2.4-2.9) 1.5 (1.3-1.6)
Disabling pain 7.4 (0–110) 11.7 (10.8-12.7) 5.0 (4.5-5.5)
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Comparison with other studies
Prevalence of chronic pain
The prevalence rate of malignant and non-malignant
pain was 26.0% in Kansas [16] and was 28.3% in
Germany. 26.8% of adult Danes reported that they have
chronic pain defined by the question “Do you have
chronic/long-lasting pain lasting 6 months or more?”
[25]. In contrast, the prevalence of chronic pain might
be higher in Asia and lower in New Zealand. The preva-
lence of chronic pain (defined by positive replies to both
question “Are you currently troubled by physical pain or
discomfort, either all the time, or on and off?”; and
“Have you had this pain or discomfort for more than
3 months?”) in adults in Hong Kong was 34.9% [26].
The prevalence of chronic pain (defined by a positive re-
sponse to the question “did you experience pain that is
present almost every day, but the intensity of the pain






Age (years) Mean (SD) 43.44 (11.60)
Education N (%)
High school or higher 282 (22.5)
Primary or secondary school 974 (77.5)
Pain grade N (%)
No pain 1024 (82.2)
Non disabling pain 179 (14.4)
Disabling pain 43 (3.5)
Disease load (Number of diseases with drug
treatment) Mean (SD)
0.37 (0.77)
*Adjusted for all other presented variables; Significant Odds ratios (OR) are markedmonths or more”) in persons aged 15 years and over in
New Zealand was 16.9% [10].
The comparison with the findings of other studies
using other definitions of chronic pain highlights the im-
pact of wording on the prevalence rates of chronic pain
in the general population. The prevalence rates ranged
from 18.5% to 19.6% in three Canadian surveys with per-
sons aged 20 years plus conducted in 1994, 1996 and
2008. Chronic pain was assessed by a “no” response to
the question “Are you usually free of pain or discom-
fort?” [27]. In contrast, the prevalence rate of chronic
pain was 32.9% in the German 2012 population survey
[14] by asking for pain over the past seven days in 19
pain areas of the body in the regional pain scale [28] and
in case of pain reports in the past seven days by a posi-
tive response to the question “Were these symptoms
above generally present for at least 3 months?”
Recently, the bodily pain scale of the Short-From





64 (45.1) Referent 0.89 (0.62-1.29) 0.54
78 (54.9) 1.14 (0.80-1.61) 0.47 Referent
43.44 (12.35) 1.00 (0.99-1.02) 0.99 0.98 (0.97-1.00) 0.94
11 (7.7) Referent Referent
161 (92.3) 3.45 (1.84-6.47) <0.0001 3.27 (1.70-6.29) <0.0001
94 (68.6) Referent Referent
21 (15.3) 1.28 (0.78-2.11) 0.34 0.87 (0.5-1.5) 0.60
22 (16.1) 5.57 (3.20-9.71) <0.0001 3.30 (1.76-6.21) <0.0001
1.06 (1.44) 1.80 (1.54-2.09) <0.0001 1.70 (1.41-2.05) <0.0001
as bold.
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a single anatomical site [5]. When defined as moderate
pain or more on at least 3 of 4 consecutive measure-
ments, the prevalence of persistent bodily pain was
26% in the general population of Norway [6]. Using
the 4-weeks time interval of the German SF-8, the
prevalence of moderate pain or more was 21.5% in our
study. In a survey including 16 European countries and
Israel, 17% of German and 30% of Norwegian partici-
pants aged 18 years or more reported moderate or se-
vere pain of at least six months duration [11]. Thus,
the prevalence rates of moderate and severe pain
showed remarkable differences between European
countries.
Prevalence of chronic pain grades
The prevalence of chronic pain based on the IASP-
definition was 35.5% in Irish adults identified by a gen-
eral practitioner data base [29]. Using the CPG, the
prevalence rate of disabling pain was 37.0% of persons
with chronic pain [29]. 21.5% of the persons with
chronic pain in the Hong Kong survey [26] met the cri-
teria of disabling pain. The percentage of persons with
disabling pain in the chronic pain group in our sample
was 27.6%. The differences in the prevalence rates of
chronic pain and its grades might be explained by differ-
ences of setting and culture. As with chronic pain, the
prevalence rates of disabling pain depend on the instru-
ments used. In the German 2012 survey of our study
group [14], 7.7% of the general population met the cri-
terion of disabling pain, as defined by the regional pain
scale [28] and by a quality of life questionnaire of the
European Organisation for Research and Treatment of
Cancer QLQ-C30 Version 3.0 [30]. In the Canadian sur-
veys the percentages of persons with disabling pain de-
fined by any limitation of activities by pain or discomfort
ranged from 11.4% to 13.3% [27].
Societal burden
In accordance with the New Zealand study [10], accu-
mulated disease load was independently associated with
chronic pain in our sample. In line with an UK prospect-
ive population with persons aged 50 years plus [31],
those with interfering pain reported more comorbidities
in our sample. Healthcare resource utilization and pe-
riods of disability increased with chronic pain stage in
our sample as it did in persons reporting severe pain
compared to those with slight or moderate pain in the
2008 National Health and Wellness Survey conducted in
five European countries [32]. Most notably, not only
stages of chronic pain, but also disease load increased
days with disability/sick leave, doctor visits and nights in
hospital as well as unemployment in our sample. In
addition, low educational level predicted unemploymentas did in a US survey [33]. Based on the biopsychosocial
model of chronic pain we assume that somatic diseases
and mental disorders predispose to chronic pain [34].
Societal inequalities increase the risk of somatic diseases
and mental disorders and vice versa [35].
Limitations
a). The response rate of 58% was comparable with the
one of recent surveys conducted in Europe [14,25], USA
[16] and Asia [26]. However, 42% of persons addressed
were non-responders. We do not know if there were
relevant differences between the participants of the sur-
vey and the ones who did not participate. Data protec-
tion laws in Germany did not allow the assessment of
demographic characteristics of non-respondents. Mar-
ginal differences in demographic characteristics between
this sample and the population imply that true rates may
vary slightly from those we report. b). We did not for-
mally use the IASP definition of chronic pain [15] to
identify persons with chronic pain. c). The design of the
study precluded an independent medical assessment for
somatic diseases and mental disorders. d). Self-reports of
days of sick leave and health care use over a 12 months
period are subject to memory bias. e). Due to German
laws of data protection we could not access health care
use and days of sick leave data of the participants avail-
able at health insurance companies. f ). Finally, the cross-
sectional design of the study did not allow determining
time course or inferring causality between chronic pain
and other variables. We asked about pain over the last
three months and burden included those three months.
Although we cannot attribute with certainty that the
burden identified was entirely due to chronic pain, it is
highly likely that at least a very large proportion of the
increased burden should be attributed to chronic pain.
Conclusion
Pain societies and researchers have made considerable
efforts to promote the awareness of the public that
chronic pain is a major health problem [2-4]. Our data
confirm the societal impact associated with chronic pain.
However, the societal burden is not only due to chronic
pain, but also due to disease load and social inequalities.
Pain, somatic diseases, mental disorders and social dis-
parities cannot be disentangled. More longitudinal stud-
ies are necessary, to investigate predictors of different
trajectories of chronic pain such as are persistent severe/
disabling, persistent mild/non-disabling and fluctuating
pain [36]. The identification of modifiable individual
psychological features of persons at increased risk for
persistent severe/disabling pain and of protective factors
promoting mild and non-disabling pain could target the
use of scarce resources [29]. A standardization of pain
measurements in epidemiology research of chronic pain
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the pain research community [5]. The pain scale of the
SF-8 has been suggested as standard measure of persistent
bodily pain in cross-sectional surveys [5]. In addition, the
chronic pain grade scale [9] enables a distinction between
disabling and non-disabling pain. Measurement of chronic
pain independent of comorbid conditions and adjustment
for associated diseases by comorbidity indices are neces-
sary for more accurate prevalence estimates of chronic
pain [10].
Additional file
Additional file 1: Comparison of demographic data of the study
sample with the general German population.
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